9 reports

  • Discovery/Preclinical Trial Details
  • AP-185 - DRUG PROFILE

There was one unrelated serious AE reported in the ## mcg group; exacerbation of pre-existing asthma due to the cold weather which required an ER visit and resolved after asthma treatment was given.

  • Dysfunction Drug
  • United States
  • World
  • Product Initiative
  • Apricus Biosciences, Inc.

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.
  • AP-185 - DRUG PROFILE
  • PVAX-HSLO - DRUG PROFILE

There was one unrelated serious AE reported in the ## mcg group; exacerbation of pre-existing asthma due to the cold weather which required an ER visit and resolved after asthma treatment was given.

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • LICENSING AGREEMENTS

The company also offers non-prescription medicines for asthma, hypertension, colds, cancer, osteoporosis, pain, Parkinson' s and other disease treatments.

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Company
  • Apricus Biosciences, Inc.
  • FEMALE SEXUAL DYSFUNCTION - PIPELINE BY RE-PHARM LTD, H1 2018

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ##, ## and ## respectively.

  • Dysfunction Drug
  • Therapy
  • United States
  • Demand
  • Palatin Technologies, Inc.
  • FEMALE SEXUAL DYSFUNCTION - PIPELINE BY PALATIN TECHNOLOGIES INC, H2 2017
  • FEMALE SEXUAL DYSFUNCTION - PIPELINE BY RE-PHARM LTD, H2 2017

Extrinsa remains an estimated $## billion opportunity.

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Palatin Technologies, Inc. - Dormant Developmental Projects,2015
  • Palatin Technologies, Inc. - Pipeline by Indication, 2015

Palatin Technologies, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Palatin Technologies, Inc. - Product Pipeline Review - 2015’, provides an overview of the Palatin Technologies, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the...

  • Dysfunction Drug
  • Therapy
  • United States
  • Company Operations
  • Palatin Technologies, Inc.

THE PHONE NUMBER TO CALL FOR THE TELECONFERENCE IS ##-##-##-## FOR U. S AND ##-##-##-## FOR CANADA AND INTERNATIONAL.

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

THE LATTER INCLUDES ILLNESSES SUCH AS BIPOLAR MOOD DISORDER AND ASTHMA.

  • Dysfunction Drug
  • Healthcare
  • Pharmaceutical
  • South Africa
  • Nedbank Limited